Status:
UNKNOWN
A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry Care
Lead Sponsor:
Data Collection Analysis Business Management
Conditions:
Toenail Fungal Infection
Cellulitis
Brief Summary
The purpose of this study is to evaluate the level of relief perceived by patients using medicated footbath/footwash with or without an oral medication for the treatment of podiatry issues.
Detailed Description
Footwash/Footbath for treatment of; Toenail fungus Ingrown toenails Cellulitis Athletes' foot Pitted Keratolysis Diabetic ulcers Open infected sores Abscesses Joint infections Wound care
Eligibility Criteria
Inclusion
- Participants must be diagnosed with an ICD10 code indicative of Toenail Fungus, Ingrown Toenail, Cellulitis, Athletes Foot, Pitted Keratolysis, Diabetic Ulcers, Open infected sores, Abscesses, and Joint infections
- Participants must be starting a new regimen of a medicated footwash/foothbath
- Participants must be expecting to receive therapy for at least 12 weeks
- Participants must be between 18 and 64 years of age
- Participants must be able to provide sound verbal informed consent
Exclusion
- \-
- Participants must not be a beneficiary of government funded healthcare program (i.e. Medicare, Medicaid, etc.)
- • Participants must not have a diagnosis of cancer within the past 5 years
Key Trial Info
Start Date :
December 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03781024
Start Date
December 1 2018
End Date
June 1 2022
Last Update
December 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
DCABM
Land O' Lakes, Florida, United States, 33558